At Investor Conferences

Advertisement

Picture Berlin Partner Health Capital Computational Biology 2022 650x100px
Organisation › Details

Athyrium Capital Management L.P.

Athyrium is a specialized asset management company formed in 2008 to focus on investment opportunities in the global healthcare sector. Athyrium advises funds with over $4.6 billion in committed capital. The Athyrium team has substantial investment experience across a wide range of asset classes including public equity, private equity, fixed income, royalties, and other structured securities. Athyrium invests across all healthcare verticals including biopharma, medical devices and products, healthcare focused services, and healthcare information technology. The team partners with management teams to implement creative financing solutions to companies' capital needs. *

 

Period Start 2014-12-12 existent
Products Industry finance
  Industry 2 healthcare
     
Region Region New York, NY
  Country United States (USA)
  Street 505 Fifth Avenue
18th Floor
  City 10017 New York, NY
  Tel +1-212-402-6925
    Address record changed: 2022-05-30
     
Basic data Employees n. a.
  Currency USD
  Annual sales 4,600,000,000 (capital, committed (2022) 2022-05-25)
     
    * Document for �About Section�: uMotif Ltd.. (5/25/22). "Press Release: uMotif – the Patient-first Data Capture and Decentralized Clinical Trials Platform – Announces $25.5m of New Investment from a Fund Managed by Athyrium Capital Management". London & New York, NY.
     
   
Record changed: 2022-05-30

Advertisement

Picture EBD Group BIO-Europe 2022 Leipzig 650x200px

More documents for Athyrium Capital Management L.P.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group BioPharm Amercia 2022 Boston 650x300px




» top